Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
8.38
-0.17 (-1.99%)
At close: Mar 17, 2026, 4:00 PM EDT
8.73
+0.35 (4.20%)
After-hours: Mar 17, 2026, 7:49 PM EDT
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $153.72 million as of March 17, 2026. Its market cap has increased by 129.78% in one year.
Market Cap
153.72M
Enterprise Value
395.92M
1-Year Change
129.78%
Ranking
Category
Stock Price
$8.38
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $153.72M, a decrease of -65.29%. That is a compound annual growth rate of -8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 156.80M | 24.94% |
| Dec 31, 2025 | 125.50M | 48.17% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
| Nov 6, 2013 | 442.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 159.09M |
| Molecular Partners AG | 157.88M |
| Artiva Biotherapeutics | 156.95M |
| Codexis | 152.66M |
| Inhibikase Therapeutics | 152.61M |
| Jyong Biotech | 152.18M |
| Vaxart | 151.84M |
| Unicycive Therapeutics | 150.44M |